Biotech News
Related news
CLDXCelldex Therapeutics2026-09-08 20:01 EST
Celldex to Present at Upcoming Investor Conference
BRLIBio-Reference Laboratories2026-09-08 17:55 EST
OPKO Health to Participate in the Wells Fargo 21st Annual Healthcare Conference
ZURAZura Bio2026-08-31 20:30 EST
Zura Bio to Participate in the Cantor Global Healthcare Conference
BDSXBiodesix2026-08-04 10:00 EST
Biodesix to Participate in Canaccord Genuity’s 46th Annual Growth Conference
AVTXAvalo Therapeutics2026-07-22 11:00 EST
Avalo Therapeutics to Participate in the BTIG Biotechnology Conference
REGNRegeneron Pharmaceuticals2026-08-19 20:05 EST
Regeneron Announces Investor Conference Presentations
XFORX4 Pharmaceuticals2026-09-09 11:00 EST
X4 Pharmaceuticals to Participate in a Fireside Chat at the 2026 Wells Fargo Healthcare Conference
BIAFbioAffinity Technologies, Inc.2026-09-03 20:30 EST
bioAffinity Technologies to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
ACRSAclaris Therapeutics2026-09-03 12:00 EST
Aclaris Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference
ANABAnaptysBio, Inc.2026-09-01 20:15 EST
Anaptys Announces Participation at the H.C. Wainwright 28th Annual Global Investment Conference
Exagen
Autoimmune Diagnostics Exagen provides diagnostic testing for autoimmune and rheumatic diseases. Its tests are designed to help clinicians resolve diagnostically complex cases and support ongoing disease management. AVISE CTD AVISE CTD is the company's flagship testing service for lupus and other connective-tissue diseases. It combines...
Recent company news
XGNExagen2026-08-04 12:00 EST
Exagen Inc. Reports Second Quarter 2026 Financial Results
XGNExagen2026-07-28 13:00 EST
Exagen Inc. to Participate in Upcoming Investor Conference
XGNExagen2026-07-21 13:00 EST
Exagen to Announce Second Quarter Financial Results on August 4, 2026
XGNExagen2026-06-01 13:00 EST
Exagen Announces Publication of Systematic Review Confirming Robust Real-World Performance of AVISE Lupus
XGNExagen2026-05-11 12:00 EST
Exagen Inc. Reports First Quarter 2026 Results
Stock data
- Close
- 8.41 USD
- Market cap
- 116.45M USD
- Exchange
- NASDAQ
- Sector
- MedTech
- Location
- United States